Several countries and companies are racing to produce vaccines and treat the Coronavirus

Capitals-SANA

Countries, companies and laboratories have raced for several times in an attempt to produce vaccines and treatment for the emerging coronavirus, which has been haunting the world because of its wide spread.

In this context, China, France, Britain and Italy have revealed that they have tested vaccines and effective treatment against the Corona virus.

The Chinese authorities announced today that they have completed the clinical research of faviravir, an antiviral drug that has shown good clinical efficacy against the emerging corona virus.

Zhang Xinmin, director of the Chinese National Center for Biotechnology Development under the Ministry of Science and Technology, said that faviravir, which is an influenza drug, was approved for clinical use in 2014 and showed no clear negative reactions in the clinical trial, indicating that (faviravir) was recommended for treatment teams. The medical must be included in the plan for diagnosis and treatment of the disease as soon as possible.

Yesterday evening, China officially approved the use of the first SKV vaccine in clinical trials.

For its part, a French pharmaceutical company announced today its willingness to provide about 300 thousand doses for the treatment of people infected with the new Corona virus, after the positive and promising results of a drug used during the treatment experience.

According to the French newspaper Le Monde, the Sanofi Drug Company made the decision to provide treatment to patients after it proved its usefulness during recent experiments, indicating that the drug is used as an anti-malarial and has proven very effective in healing the patients of the emerging corona virus.

Also, the British government's scientific advisor, Patrick Valance, announced in a press conference that his country has made great progress in installing a new vaccine against Corona virus, indicating that it may be ready in the spring of next year.

For his part, Nicolas Magrini, head of the National Medicines Agency in Italy, announced that the tests of the drug (Tocelizumab) used in treating rheumatoid arthritis to treat the Corona virus will begin on Thursday in Italy, pointing out that preliminary studies have shown encouraging results.

Magrini indicated that about 330 patients will participate in the tests.

Several countries are working to prepare vaccines against the emerging coronavirus, which started spreading from the Chinese city of Wuhan late last year and infected at least 200,000 people in about 150 countries.